Nippon Kayaku Co (4272) Q3 2026 earnings summary

Executive summary

• Net sales for FY2025 3Q reached ¥174.6 billion, up 4.0% year-over-year, with profit attributable to owners of parent rising 30.1% to ¥17.3 billion, but operating income declined 9.9% to ¥16.3 billion.

• Segment performance was mixed: Mobility & Imaging saw higher sales but lower profit, Fine Chemicals declined in both, while Life Science improved in both sales and profit.

• Full-year forecasts remain unchanged, projecting sales of ¥239.8 billion (+7.7% YoY), operating income of ¥21.3 billion (+4.4%), and profit of ¥20.4 billion (+16.5%).

Financial highlights

• Gross profit margin decreased to 29.9% from 32.3% year-over-year.

• Operating income margin fell to 9.3% from 10.8% YoY.

• Comprehensive income for the first three quarters reached ¥29,689 million, up 119.9% YoY.

• EPS for the period was ¥112.39, up from ¥81.02 in the prior year.

• Total assets as of December 31, 2025, were ¥405,997 million, with net assets at ¥274,087 million.

Outlook and guidance

• Full-year sales and operating income forecasts remain unchanged from November.

• Full-year EPS forecast is ¥133.54.

• Catalyst sales expected to be concentrated in 4Q; Functional Materials and Pharmaceuticals to perform steadily.

• Mobility & Imaging outlook remains sluggish due to high raw material costs and inventory adjustments.